Latest Security News

ASPI Isotopes Inc. has proposed a scheme to acquire all Renergen shares at a 41.3% premium, aiming to create a global critical materials powerhouse. The deal, subject to shareholder and regulatory approval, will delist Renergen from multiple exchanges.

Renergen Limited shareholders have received a detailed circular outlining ASP Isotopes Inc.'s firm intention to acquire the company through a scheme of arrangement, with a general meeting scheduled for 10 July 2025 to approve the deal.

Miramar Resources has partnered with Topdrill in a drill-for-equity agreement to fund significant drilling at the promising 8 Mile gold target within its Gidji JV Project near Kalgoorlie. Drilling is set to begin in July, aiming to explore extensions of a known gold deposit.

NexGen Energy has secured regulatory approval for a significant infrastructure upgrade at its Rook I uranium project, setting the stage for expanded exploration and operational efficiency in 2025.

Challenger Limited has welcomed APRA’s consultation on new capital settings for annuity products, highlighting the potential for regulatory reforms to boost innovation and growth in Australia’s retirement income sector.

PointsBet Holdings has secured Foreign Investment Review Board approval for MIXI Australia's proposed full acquisition, marking a key regulatory milestone in the takeover process.

Hazel Group Limited has temporarily paused trading of its securities on the ASX, signaling an impending announcement that investors will want to watch closely.

Peninsula Energy has resolved outstanding claims with its EPC contractor and is advancing a reset plan for its Lance uranium project, including revised production guidance and funding strategies.

Aureka Limited has raised $3 million through a share placement to accelerate exploration and secure land access at its key gold projects in Victoria, signalling strong investor confidence in its growth strategy.

Hawsons Iron Ltd has been reinstated to ASX trading following an announcement of a proposed capital raising, signaling renewed investor interest.

Ragusa Minerals has terminated its binding agreement with Geopolymer Industries due to unmet conditions, reaffirming its commitment to the Burracoppin rare earths project and exploring fresh opportunities.

Mesoblast reports positive FDA progress on accelerated approval for Revascor in ischemic heart failure and plans a pivotal trial to extend Ryoncil’s label to adults with graft versus host disease, while its US commercial launch outpaces expectations.